Ardelyx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. 

CEO
Michael G. Raab
CEOMichael G. Raab
Employees
267
Employees267
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2007
Founded2007
Employees
267
Employees267

ARDX Key Statistics

Market cap
1.51B
Market cap1.51B
Price-Earnings ratio
-21.19
Price-Earnings ratio-21.19
Dividend yield
Dividend yield
Average volume
4.99M
Average volume4.99M
High today
$6.56
High today$6.56
Low today
$6.27
Low today$6.27
Open price
$6.35
Open price$6.35
Volume
5.64M
Volume5.64M
52 Week high
$10.13
52 Week high$10.13
52 Week low
$3.16
52 Week low$3.16

ARDX News

Simply Wall St 3d
Ardelyx, Inc.'s Popularity With Investors Is Under Threat From Overpricing - Simply Wall St

It's not a stretch to say that Ardelyx, Inc.'s ( ) price-to-sales (or "P/S") ratio of 12.7x right now seems quite "middle-of-the-road" for companies in the Biot...

Ardelyx, Inc.'s Popularity With Investors Is Under Threat From Overpricing - Simply Wall St

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.